C David Sjöström

8PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersTime-series analysisCardiology (incl. cardiovascular diseases)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 28, 2026
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis.

|Jan 26, 2026
A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.

Hiddo J L Heerspink, Dustin J Little, Samvel B Gasparyan

|Apr 29, 2023
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial.

Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart

|Apr 25, 2020
Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials.

Annemarie B van der Aart-van der Beek, Daniel H van Raalte, Cristian Guja

Pageof 2

Frequent Collaborators

7 joint publications

Hiddo J L Heerspink

5 joint publications

Glenn M Chertow

5 joint publications

Peter Rossing

4 joint publications

Roberto D Toto